The AngioVac System is AngioDynamics’ innovative, on-circuit aspiration option. The system provides surgical results via percutaneous access by simultaneously reinfusing blood back in the patient’s …

The AngioVac system, developed by AngioDynamics, Inc., is a catheter-based device initially designed for percutaneous intravascular thrombectomy and embolectomy.

Apr 11, 2025 · The AngioVac system is primarily indicated for the removal of unwanted intravascular material, such as fresh, soft thrombi or emboli, in the venous system, right heart, and pulmonary …

The AngioVac F22 cannula technology is AngioDynamics' Proprietary Funnel Tip Design that allows for potentially easier navigation and placement throughout the patient's venous system.

While there are minimally invasive therapies available, the AngioVac System facilitates the en bloc removal of fresh, soft thrombi or emboli. AngioVac can be utilized in a wide range of areas from the …

The AngioVac suction has been approved by the Food and Drug Association since 2014 for the removal of undesirable materials from the intravascular system such as thrombi in the iliocaval, pulmonary, or …

Jul 15, 2024 · We retrospectively reviewed all patients who underwent the AngioVac procedure performed by a cardiac surgeon between August 2019 and December 2022. Fellowship-trained …

Apr 5, 2024 · The AngioVac© system is an FDA approved, on-circuit, venous aspiration device utilizing extracorporeal bypass for thrombus aspiration, which off-label, can safely be used for vegetation …

Feb 7, 2021 · The AngioVac System (AngioDynamics, Latham, NY) has been recently introduced in the surgical armamentarium and initially devised to allow suction of soft thrombi from the right atrium and …

The AngioVac (AngioDynamics) system has emerged as the first aspiration thrombectomy device capable of removing significant intravascular material—such as thrombus, vegetation and …